No Data
No Data
Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says
Moderna's (MRNA) newly approved respiratory syncytial virus vaccine may achieve stronger than expected US penetration despite entering a market with two seasoned competitors, Oppenheimer said in a Wed
Express News | World Health Organization Chief: At This Time, Who Continues To Assess Risk To Public Health From H5n1 As Low
GSK Starts Appeal Process Against Delaware Court Decision Allowing Expert Testimonies in Zantac Litigation
GSK (GSK) said Monday it started the appeal process of a recent ruling by the Delaware Superior Court to allow plaintiff expert testimony in the litigation related to the heartburn drug Zantac.
GSK's Zantac Litigation Concerns Are Overblown -- Market Talk
0925 GMT - GSK's Zantac litigation has disproportionately weighed on the share since the demerger of Haleon and overshadowed its improving growth outlook, Shore Capital Markets analyst Sean Conroy say
Zantac's cancer lawsuit continues to be reviewed, and GlaxoSmithKline (GSK.US) has filed an appeal.
According to Zhicheng Finance APP, GlaxoSmithKline (GSK.US) and other pharmaceutical companies have appealed the ruling allowing Zantac carcinogenic lawsuits to continue in Delaware. It is reported that this ruling allows more than 70,000 lawsuits claiming that the anti-heartburn drug Zantac can cause cancer to continue to be tried. This ruling has caused a sharp drop in GlaxoSmithKline's stock price. If Judge Vivian Medinilla of the Delaware Superior Court approves the appeal request filed by companies including Pfizer (PFE.US), Sanofi (SNY.US) and Boehringer Ingelheim, the appeal will be submitted directly.
GSK Sees Dismissal of US Zantac Case Without Settlement
GSK (GSK.L) said Monday that a case related to its heartburn drug Zantac in the US state of Illinois was voluntarily dismissed by the plaintiff. The case was expected to go to trial the same day. The
No Data
SanjBot : nothing like a few gallstones to make you feel alive.